Drug application
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE, LIDOCAINE HYDROCHLORIDE)
Drugs@FDA NDA 021486 · EMPI
Key facts
| Drug name | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE |
|---|---|
| Active ingredients | EPINEPHRINE, LIDOCAINE HYDROCHLORIDE |
| Application type | NDA |
| Application number | 021486 |
| Company | EMPI |
| Dosage forms | SOLUTION, IONTOPHORESIS, TOPICAL |
| Strength | 0.01MG/ML;2% |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 4 - New Combination |
| Latest submission status date | Oct 26, 2004 |
At a glance
- 1–9 Submissions
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: